We are monitoring the impact of COVID-19 on MEA Ablation Technologies Market Get in touch with us for detailed analysis Know More
Share on

Middle East and Africa Ablation Technologies Market Research Report - Segmented By Product, Type, Application and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2102
Pages: 145

MEA Ablation Technologies Market Size (2022 to 2027)

The Ablation Technologies Market size in the Middle East & Africa has been valued at USD 297.44 Million in 2022 and is projected to reach USD 510.30 Million by 2027, at a CAGR of 11.40% between 2022 to 2027.

The rising number of cancer and cardiac arrests, the growing geriatric population, and shifting to the preference for minimal non-invasive procedures are likely to accelerate the growth of the MEA ablation technology market during the forecast period. According to statistics from the World Health Organization, nearly 17.56 million deaths each year are associated with cardiovascular disease, of which atrial defibrillation is a significant disorder. In addition, the incidence of atrial fibrillation increases with age, affecting almost one in 20 people aged 65 and over.

Ablation has various advantages over traditional treatment procedures like more minor surgical complications, less risk of infection, shorter hospital stays, reduced post-operative care, less pain, faster recovery, smaller incisions, and better aesthetic and low-risk infections. In addition, ablation has successfully removed cancerous growths and lymph nodes for diagnostic biopsies and staging studies. This helps surgeons to develop accurate and appropriate cancer treatment plans. According to WHO statistics, in 2019, more than 19 million people worldwide would have developed new types of cancer, around 39 million people are believed to be suffering from cancer, and more than 10 million deaths due to cancer-induced complications. Thus, the constant increase in the number of patients with cancer and cardiovascular diseases will lead to significant demand for ablation procedures in the years to come. All these factors will generate several opportunities which lead to the growth of the MEA ablation technologies market during the forecast period.

However, the high cost of the ablation process and the rigid regulatory approval process are likely to slow the growth of the ablation technology market during the forecast period mentioned above. In addition, specific therapeutic challenges related to the effectiveness of ablation techniques such as scarring, pigmentation, and others are key challenges faced by the market.

The availability of effective conventional therapies as a significant/ first-line of treatment option is an essential constraint to the market's growth. Conventional therapies such as surgery, chemotherapy, and radiation therapy are preferred as cancer treatment due to the widespread awareness of these traditional modalities, low uptake of advanced treatment options, and the reluctance of oncologists to switch to conventional treatments, especially in developing economies.

This research report on the MEA ablation technologies market has been segmented and sub-segmented into the following categories.

By Product: 

  • Light/Laser Ablators
  • Radiofrequency (RF) Ablators
  • Electrical Ablators
  • Ultrasound Ablators
  • Microwave Ablators
  • Cryoablation Devices
  • Hydrothermal Ablators

By Type: 

  • Light/Laser Ablation
  • Radiofrequency Ablation
  • Electrical Ablation
  • Ultrasound Ablation
  • Cryoablation
  • Microwave Ablation
  • Hydrothermal Ablation

By Application: 

  • Cardiovascular Disease Treatment
  • Cancer Treatment
  • Ophthalmologic Treatment
  • Gynecologic Treatment
  • Pain Management
  • Urologic Treatment
  • Orthopedic Treatment
  • Cosmetic Surgery
  • Other Treatments  

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the Middle East dominates the MEA ablation technologies market due to the rapid growth of the technologies, high rate of adoption of ablation devices, and extensive senior population. On the other hand, the regional market in the United Arab Emirates, Qatar, Oman, and Saudi Arabia is anticipated to experience a steady growth rate due to the large population base, increasing healthcare expenditure, good reimbursement policies, and high prevalence of cancer.

Emerging markets in Turkey, Kuwait, Bahrain, and Egypt will see good growth opportunities in the MEA ablation technology market, owing to factors such as initiatives undertaken by public and private sectors, continuous improvements in healthcare infrastructure, growing patient healthcare awareness, and availability of ablation devices.

Regions in Africa will also see growth due to relatively low treatment procedures and improving spending on medical care. In addition, there is also increased incidence and prevalence of lifestyle-related diseases, such as heart disease and cancer.

KEY MARKET PLAYERS:

Companies playing a leading role in the Middle East & Africa ablation technologies market profiled in the report are Biosense Webster, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., Smith & Nephew plc, Galil Medical Inc., CONMED Corporation, Olympus Corporation, Covidien PLC, Medtronic, Inc., and BSD Medical Corporation.

1.Introduction  

   1.1 Market Definition 

   1.2 Study Deliverables            

   1.3 Base Currency, Base Year and Forecast Periods       

   1.4 General Study Assumptions          

2. Research Methodology     

   2.1 Introduction            

   2.2 Research Phases   

2.2.1 Secondary Research     

2.2.2 Primary Research 

2.2.3 Econometric Modelling

2.2.4 Expert Validation  

   2.3 Analysis Design      

   2.4 Study Timeline       

3. Overview 

   3.1 Executive Summary          

   3.2 Key Inferences      

   3.3 Epidemology           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)    

   4.1 Market Drivers       

   4.2 Market Restraints 

   4.3 Key Challenges      

   4.4 Current Opportunities in the Market           

5. Market Segmentation        

   5.1 Product     

5.1.1 Introduction     

5.1.2 Light/Laser ablators       

          5.1.2.1 Excimer laser ablators  

          5.1.2.2 Cold laser ablators         

5.1.3 Radiofrequency (RF) ablators   

          5.1.3.1 Temperature-controlled RF ablators     

          5.1.3.2 Fluid-cooled RF ablators   

          5.1.3.3 Robotic catheter manipulation systems     

5.1.4 Electrical ablators 

          5.1.4.1 Argon plasma/beam coagulators            

          5.1.4.2 Irreversible electroporation ablators    

5.1.5 Ultrasound ablators      

          5.1.5.1 High-intensity focused ultrasound (HIFU) ablators         

          5.1.5.2 Magnetic resonance guided focused ultrasound (MRGFUS) ablators     

          5.1.5.3 Ultrasonic surgical ablation systems      

          5.1.5.4 Extracorporeal shockwave lithotripsy systems 

5.1.6 Microwave ablators      

          5.1.6.1 Microwave thermotherapy ablators     

5.1.7 Cryoablation devices    

          5.1.7.1 Tissue contact probe ablators  

          5.1.7.2 Tissue spray probe ablators      

          5.1.7.3 Epidermal and subcutaneous cryoablation systems       

5.1.8 Hydrothermal ablators 

          5.1.8.1 Endothermal hydrothermal balloon ablation devices     

5.1.9  Y-o-Y Growth Analysis, By Product        

5.1.10  Market Attractiveness Analysis, By Product    

5.1.11  Market Share Analysis, By Product      

   5.2 Type           

5.2.1 Introduction     

5.2.2 Light/Laser Ablation      

5.2.3 Radiofrequency Ablation  

5.2.4 Electrical Ablation 

5.2.5 Ultrasound Ablation      

5.2.6 Cryoablation     

5.2.7 Microwave Ablation      

5.2.8 Hydrothermal Ablation

5.2.9  Y-o-Y Growth Analysis, By Type    

5.2.10  Market Attractiveness Analysis, By Type          

5.2.11  Market Share Analysis, By Type  

   5.3 Application           

5.3.1 Introduction     

5.3.2 Cardiovascular Disease Treatment

5.3.3 Cancer Treatment

5.3.4 Ophthalmologic Treatment        

5.3.5 Gynecologic Treatment     

5.3.6 Pain Management         

5.3.7 Urologic Treatment       

5.3.8 Orthopedic Treatment 

5.3.9 Cosmetic Surgery 

5.3.10 Other Treatments       

5.3.11  Y-o-Y Growth Analysis, By Application     

5.3.12  Market Attractiveness Analysis, By Application   

5.3.13  Market Share Analysis, By Application     

6. Geographical Analysis        

   6.1 Introduction            

6.1.1 Regional Trends    

6.1.2 Impact Analysis     

6.1.3 Y-o-Y Growth Analysis  

          6.1.3.1 By Geographical Area  

          6.1.3.2 By Product        

          6.1.3.3 By Type    

          6.1.3.4 By Application 

6.1.4  Market Attractiveness Analysis     

          6.1.4.1 By Geographical Area  

          6.1.4.2 By Product        

          6.1.4.3 By Type    

          6.1.4.4 By Application 

6.1.5  Market Share Analysis

          6.1.5.1 By Geographical Area  

          6.1.5.2 By Product        

          6.1.5.3 By Type    

          6.1.5.4 By Application 

   6.2 Middle-East

   6.3 Africa         

7.Strategic Analysis  

   7.1 PESTLE analysis      

7.1.1 Political     

7.1.2 Economic 

7.1.3 Social   

7.1.4 Technological   

7.1.5 Legal    

7.1.6 Environmental 

   7.2 Porter’s Five analysis           

7.2.1 Bargaining Power of Suppliers  

7.2.2 Bargaining Power of Consumers    

7.2.3 Threat of New Entrants     

7.2.4 Threat of Substitute Products and Services        

7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis   

   8.1 Biosense Webster, Inc.      

8.1.1 Overview 

8.1.2 Product Analysis   

8.1.3 Financial analysis  

8.1.4 Recent Developments 

8.1.5 SWOT analysis 

8.1.6 Analyst View    

   8.2 St. Jude Medical, Inc.          

   8.3 Boston Scientific Corporation          

   8.4 AngioDynamics, Inc.            

   8.5 AtriCure, Inc.          

   8.6 Smith & Nephew plc            

   8.7 Galil Medical Inc.   

   8.8 CONMED Corporation         

   8.9 Olympus Corporation          

   8.10 Covidien PLC         

   8.11 Medtronic, Inc.    

   8.12 BSD Medical Corporation

9.Competitive Landscape      

   9.1 Market share analysis         

   9.2 Merger and Acquisition Analysis    

   9.3 Agreements, collaborations and Joint Ventures      

   9.4 New Product Launches      

10.Market Outlook and Investment Opportunities    

Appendix     

   a) List of Tables          

   b) List of Figures

  1. Middle East & Africa Ablation Technologies Market, By Product, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Light/Laser ablators Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Radiofrequency (RF) ablators Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Electrical ablators Market, By Region, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Ultrasound ablators Market, By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Microwave ablators Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Cryoablation devices Market, By Region, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Hydrothermal ablators Market, By Region, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Ablation Technologies Market, By Type, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Light/Laser Ablation Market, By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Radiofrequency Ablation Market, By Region, From 2022 - 2027 (USD Million)
  12. Middle East & Africa Electrical Ablation Market, By Region, From 2022 - 2027 (USD Million)
  13. Middle East & Africa Ultrasound Ablation Market, By Region, From 2022 - 2027 (USD Million)
  14. Middle East & Africa Cryoablation Market, By Region, From 2022 - 2027 (USD Million)
  15. Middle East & Africa Microwave Ablation Market, By Region, From 2022 - 2027 (USD Million)
  16. Middle East & Africa Hydrothermal Ablation Market, By Region, From 2022 - 2027 (USD Million)
  17. Middle East & Africa Ablation Technologies Market, By Application, From 2022 - 2027 (USD Million)
  18. Middle East & Africa Cardiovascular Disease Treatment Market, By Region, From 2022 - 2027 (USD Million)
  19. Middle East & Africa Cancer Treatment Market, By Region, From 2022 - 2027 (USD Million)
  20. Middle East & Africa Ophthalmologic Treatment Market, By Region, From 2022 - 2027 (USD Million)
  21. Middle East & Africa Gynecologic Treatment Market, By Region, From 2022 - 2027 (USD Million)
  22. Middle East & Africa Pain Management Market, By Region, From 2022 - 2027 (USD Million)
  23. Middle East & Africa Urologic Treatment Market, By Region, From 2022 - 2027 (USD Million)
  24. Middle East & Africa Orthopedic Treatment Market, By Region, From 2022 - 2027 (USD Million)
  25. Middle East & Africa Cosmetic Surgery Market, By Region, From 2022 - 2027 (USD Million)
  26. Middle East & Africa Other treatments Market, By Region, From 2022 - 2027 (USD Million)
  27. Middle East Ablation Technologies Market, By Product, From 2022 - 2027 (USD Million)
  28. Middle East Ablation Technologies Market, By Type, From 2022 - 2027 (USD Million)
  29. Middle East Ablation Technologies Market, By Application, From 2022 - 2027 (USD Million)
  30. Africa Ablation Technologies Market, By Product, From 2022 - 2027 (USD Million)
  31. Africa Ablation Technologies Market, By Type, From 2022 - 2027 (USD Million)
  32. Africa Ablation Technologies Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample